ArticleMedicine2025
Association between hemoglobin glycation index and low bone mineral density in postmenopausal women: An analysis of data from the NHANES database.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The hemoglobin glycation index (HGI), a valuable indicator reflecting individual variations in glycosylated hemoglobin (HbA1c), serves as a crucial measure of glucose metabolism, which may influence bone health. This study aimed to elucidate the association between HGI and low bone mineral density (BMD) in postmenopausal women. Utilizing data from the National Health and Nutrition Examination Survey database across the years 2005 to 2010, 2013 to 2014, and 2017 to 2018, we defined low BMD as a T-score ≤ -1.0 and employed logistic regression models to investigate the HGI-BMD relationship, further stratifying the analysis based on dietary antioxidant quality score (DAQS) classifications. From 1961 postmenopausal women included in our analysis, 1197 (60.56%) exhibited low BMD, with results indicating that women with HGI ≥ -0.0835 had elevated odds of low BMD (odds ratio [OR] = 1.47, 95% confidence interval [CI]: 1.09-1.98) compared to their counterparts with HGI < -0.0835. Notably, this association manifested significantly in participants with DAQSs <5 (OR = 1.44, 95% CI: 1.00-2.07, P = .049) while remaining absent among those with higher DAQSs. Subgroup analyses revealed that the increased odds of low BMD were predominant in women aged ≥65 years (OR = 1.80, 95% CI: 1.29-2.52) and those without a history of fractures (OR = 1.57, 95% CI: 1.16-2.13). Consequently, our findings endorse the hypothesis that elevated HGI correlates with a greater risk of low BMD in postmenopausal women, a relationship potentially modulated by dietary antioxidant intake, highlighting the need for further exploration of interventions targeting metabolic pathways influencing bone density.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.